This 1986 retrospective multi-institutional study compared oncologic outcomes in 227 patients with distal femoral osteosarcoma treated by three surgical strategies. It asked whether limb-salvage surgery was oncologically equivalent to above-the-knee amputation or hip disarticulation. Median follow-up was 5.5 years.
When a patient with distal femoral osteosarcoma comes to your tumor board, the default surgical strategy is limb-salvage — and this paper is the reason why.
Before 1986, most surgeons performed amputations as the standard, with some advocating hip disarticulation over above-knee amputation out of concern that less radical resection was unsafe. Simon et al. Showed that fear was unfounded: local recurrence, metastasis, and survival were statistically identical across all three approaches (p = 0.8).
The practical rule: when adequate surgical margins can be achieved, limb-salvage is oncologically equivalent to amputation. The decision to amputate should be driven by inability to achieve clear margins or vascular/soft tissue involvement. Not by a belief that more radical surgery improves survival.
The broader lesson for boards: in osteosarcoma, metastatic biology (not surgical approach) determines survival. More than half of patients developed metastases regardless of which operation was performed.
This 1986 retrospective multi-institutional study compared oncologic outcomes in 227 patients with distal femoral osteosarcoma treated by three surgical strategies. It asked whether limb-salvage surgery was oncologically equivalent to above-the-knee amputation or hip disarticulation. Median follow-up was 5.5 years.
When a patient with distal femoral osteosarcoma comes to your tumor board, the default surgical strategy is limb-salvage — and this paper is the reason why.
Before 1986, most surgeons performed amputations as the standard, with some advocating hip disarticulation over above-knee amputation out of concern that less radical resection was unsafe. Simon et al. Showed that fear was unfounded: local recurrence, metastasis, and survival were statistically identical across all three approaches (p = 0.8).
The practical rule: when adequate surgical margins can be achieved, limb-salvage is oncologically equivalent to amputation. The decision to amputate should be driven by inability to achieve clear margins or vascular/soft tissue involvement. Not by a belief that more radical surgery improves survival.
The broader lesson for boards: in osteosarcoma, metastatic biology (not surgical approach) determines survival. More than half of patients developed metastases regardless of which operation was performed.